Skip to content
Catalyst

berberineFinding

Berberine inhibits NLRP3

lowersVery limited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Compared with the findings in 5-FU group, the expression level of NLRP3 in the spleen significantly decreased and that of IL-10 significantly increased in the Ber-CD and Con-Ber groups (p < 0.05).”
Quoted verbatim from Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents.
This finding among the 3 findings on its endpoint

berberine

NLRP3

inhibits

Who
C57BL/6 mice with 5-fluorouracil-induced intestinal mucositis, spleen
Dose studied
native berberine (Con-Ber) 5 mg/kg/day, intraperitoneal, days 3-5

Very limited evidencePMID 36903391 · 2023

02 · The study

Study
animal · not in humans
Duration
3 days

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3P2TTYGH2MNRE3168YNFV9V